Search
Research
Kadadjiny Dwank (listening, thinking and learning with your ears), Otitis Media from an urban Aboriginal perspectiveDeborah Peter Lehmann Richmond D PC AO, MBBS, MSc MBBS MRCP(UK) FRACP Honorary Emeritus Fellow Head, Vaccine Trials Group Honorary Emeritus Fellow
Research
Lung function in a model of a paediatric metabolic diseaseAlexander Larcombe A BScEnv (Hons) PhD Team Leader, Respiratory Environmental Health Team Leader, Respiratory Environmental Health Associate
Research
Metabolomics to predict asthma in children (MAP Study)Childhood asthma begins as wheeze (a whistling sound produced by the airways during breathing) during preschool age.
Research
Microbiological and immunological factors predicting surgical outcomes for chronic otitis mediaLea-Ann Peter Ruth Kirkham Richmond Thornton LK PC RT PhD MBBS MRCP(UK) FRACP PhD Co-Head, Bacterial Respiratory Infectious Disease Group;
Research
Modelling to support Australia's COVID-19 responseNick Nicholas Sherlynn Golding Tierney Ang NG NT SA BSc DPhil B.Psych.Sci (Hons), PhD (Statistics) BSc(Hons) Honorary Research Fellow Research
Research
Multi-centre, multi-disciplinary study using a systems biology approach to investigate immunomodulation in children with acute wheezeIngrid Pat Laing Holt IL PG BSc PhD PhD, DSc, FRCPath, FRCPI, FAA Head, Children's Respiratory Science Emeritus Honorary Researcher 6319 1828
Research
OPTIMUM: OPTimising IMmunisation Using Mixed schedulesPat Peter Susan Tom Jennifer Holt Richmond Prescott Snelling Kent PG PC SL T J PhD, DSc, FRCPath, FRCPI, FAA MBBS MRCP(UK) FRACP MBBS BMedSci PhD
Research
Parent Child Assistance Program - A Pilot Study in PerthMartyn Amy Symons Finlay-Jones MS AFJ B.A. (Hons) PhD. BPsych(Hons), MPsych(Clinical), MHealthEcon, PhD (Clin Psych) Honorary Research Associate Head
Research
Pina Karnpi: Kalgoorlie Otitis Media Research ProjectDeborah Lehmann D AO, MBBS, MSc Honorary Emeritus Fellow Honorary Emeritus Fellow Clinical Associate Professor Deborah Lehmann is a medical
Research
SJ-ELiOT: St Jude - Phase 1 Evaluation of LY2606368, Molecularly-Targeted CHK1/2i Therapy, in Combination with Cyclophosphamide or Gemcitabine for Children and Adolescents with Refractory or Recurrent Medulloblastoma Brain TumoursNick Raelene Gottardo Endersby NG R MBChB FRACP PhD BSc (Hons) PhD Co-Head, Brain Tumour Research Brainchild Fellow; Co-Head, Brain Tumour Research